Advil ads take all-in-one approach

Share this article:
Advil ads take all-in-one approach
Advil ads take all-in-one approach
Wyeth Consumer Health has launched a TV and print ad campaign for Advil advising consumers that they can do more with fewer bottles of OTC pain meds clogging up their purses, thanks to “The Every Pain Reliever.”

The tagline for the ads, by Grey Group, is “Yes, Advil.” One opens on a young woman tossing a squealing child in the air. “One more time, mommy,” says the child, and mommy, recalling taking different medicines for backache, headache and joint pains, dubs Advil “my every pain reliever.”

The two 30-second and 15-second TV spots are running nationally on broadcast and cable outlets including ABC, CBS, Fox, USA, TBS, TNT, Lifetime and HGTV against such programs as Survior, How I Met Your Mother, Dancing With the Stars, Good Morning America and The Today Show. Print ads are appearing in mags including Better Homes and Gardens, Good Housekeeping, Redbook, Cooking Light and National Geographic.

“Consumers can trust that they'll find the relief they need for multiple pains when they choose Advil, allowing them to pursue the activities they are really passionate about without worry,” said Wyeth Consumer Healthcare VP analgesics marketing Christopher Rich in a statement.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...